715 related articles for article (PubMed ID: 9455833)
21. Ovarian function during use of a levonorgestrel-releasing IUD.
Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
[TBL] [Abstract][Full Text] [Related]
22. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
23. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium.
Ammälä M; Nyman T; Strengell L; Rutanen EM
Fertil Steril; 1995 Apr; 63(4):773-8. PubMed ID: 7890061
[TBL] [Abstract][Full Text] [Related]
24. Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.
Shi JP; Wu XR
J Tongji Med Univ; 1993; 13(2):126-8. PubMed ID: 8230357
[TBL] [Abstract][Full Text] [Related]
25. The levonorgestrel-releasing intrauterine device.
Toivonen J
Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
[TBL] [Abstract][Full Text] [Related]
26. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
27. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
28. Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception.
Durand M; Koistinen R; Chirinos M; Rodríguez JL; Zambrano E; Seppälä M; Larrea F
Contraception; 2010 Dec; 82(6):526-33. PubMed ID: 21074015
[TBL] [Abstract][Full Text] [Related]
29. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of intrauterine devices: biochemical changes.
Johannisson E
Contraception; 1987 Jul; 36(1):11-22. PubMed ID: 3311620
[TBL] [Abstract][Full Text] [Related]
31. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
32. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
Andersson K; Odlind V; Rybo G
Contraception; 1994 Jan; 49(1):56-72. PubMed ID: 8137626
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of action of intrauterine devices.
Ortiz ME; Croxatto HB; Bardin CW
Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S42-51. PubMed ID: 8972502
[TBL] [Abstract][Full Text] [Related]
34. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
Souza JP; Andrade AT; Pizarro E
Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
[TBL] [Abstract][Full Text] [Related]
35. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
[TBL] [Abstract][Full Text] [Related]
36. [The effect of intrauterine contraceptive devices on the endometrium].
Sheppard BL; Bonnar J
Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
[TBL] [Abstract][Full Text] [Related]
37. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
[TBL] [Abstract][Full Text] [Related]
38. Emergency contraception: a review.
Haspels AA
Contraception; 1994 Aug; 50(2):101-8. PubMed ID: 7956209
[TBL] [Abstract][Full Text] [Related]
39. New developments in intrauterine devices.
Farr G
Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
[TBL] [Abstract][Full Text] [Related]
40. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
